Literature DB >> 20227033

Gastrointestinal and liver side effects of drugs in elderly patients.

Konstantinos Triantafyllou1, Jiannis Vlachogiannakos, Spiros D Ladas.   

Abstract

It is expected that the percentage of people >60 years of age will be 22% worldwide by the year 2050. Multi-morbidity and poly-pharmacy are common in individuals during old age, while adverse drug reactions are at least twice as common in the elderly compared to younger adults. Publications related to drug side effects are rather rare in this age group since most clinical trials exclude patients >75-80 years of age. Gastrointestinal adverse drug reactions studied in the elderly include non-steroidal anti-inflammatory drugs (NSAIDs) and anticoagulant-induced gastrointestinal tract mucosal injuries. Malabsorption, diarrhoea and constipation are common side effects of laxatives, antibiotics, anticholinergics and calcium channel blockers. Drug (amoxycilin/clavulanic acid, isoniazide, nitrofurantoin, diclifenac and methotrexate)-induced hepatotoxicity in the elderly is four times more common than in younger adults and may simulate almost all known liver disorders. Further clinical studies are needed to investigate gastrointestinal and hepatic side effects of drugs in elderly patients. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20227033     DOI: 10.1016/j.bpg.2010.02.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  17 in total

1.  Nitrofurantoin-induced life-threatening seizures.

Authors:  Matej Stuhec; Vesna Svab
Journal:  Wien Klin Wochenschr       Date:  2012-08-01       Impact factor: 1.704

2.  Prevalence of constipation in the German population - a representative survey (GECCO).

Authors:  Paul Enck; Johannes Leinert; Menno Smid; Thorsten Köhler; Juliane Schwille-Kiuntke
Journal:  United European Gastroenterol J       Date:  2015-08-21       Impact factor: 4.623

Review 3.  Auditory hallucinations associated with nitrofurantoin use: case report and review of the literature.

Authors:  Matej Štuhec
Journal:  Wien Klin Wochenschr       Date:  2014-08-15       Impact factor: 1.704

4.  Microglial cathepsin B contributes to the initiation of peripheral inflammation-induced chronic pain.

Authors:  Li Sun; Zhou Wu; Yoshinori Hayashi; Christoph Peters; Makoto Tsuda; Kazuhide Inoue; Hiroshi Nakanishi
Journal:  J Neurosci       Date:  2012-08-15       Impact factor: 6.167

Review 5.  Lesions in the oral cavity and esophagus caused by prescribed drugs: A review.

Authors:  Snezana Tesic-Rajkovic; Biljana Radovanovic-Dinic
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

Review 6.  Drug-induced liver injury in the elderly.

Authors:  Jonathan G Stine; Praveen Sateesh; James H Lewis
Journal:  Curr Gastroenterol Rep       Date:  2013-01

7.  Microbial-mammalian cometabolites dominate the age-associated urinary metabolic phenotype in Taiwanese and American populations.

Authors:  Jonathan R Swann; Konstantina Spagou; Matthew Lewis; Jeremy K Nicholson; Dana A Glei; Teresa E Seeman; Christopher L Coe; Noreen Goldman; Carol D Ryff; Maxine Weinstein; Elaine Holmes
Journal:  J Proteome Res       Date:  2013-06-24       Impact factor: 4.466

8.  Inclusion of cocoa as a dietary supplement represses expression of inflammatory proteins in spinal trigeminal nucleus in response to chronic trigeminal nerve stimulation.

Authors:  Ryan J Cady; Jennifer E Denson; Paul L Durham
Journal:  Mol Nutr Food Res       Date:  2013-04-11       Impact factor: 5.914

9.  Autoimmune liver disease - are there spectra that we do not know?

Authors:  Hind I Fallatah; Hisham O Akbar
Journal:  Comp Hepatol       Date:  2011-09-12

Review 10.  Aging of the human metaorganism: the microbial counterpart.

Authors:  Elena Biagi; Marco Candela; Susan Fairweather-Tait; Claudio Franceschi; Patrizia Brigidi
Journal:  Age (Dordr)       Date:  2011-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.